Filing Details

Accession Number:
0001209191-19-057149
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-19 16:16:36
Reporting Period:
2019-11-15
Accepted Time:
2019-11-19 16:16:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204788 M David Stack C/O Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Ceo And Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-15 45,000 $42.81 142,299 No 4 S Direct
Common Stock Acquisiton 2019-11-15 25,000 $10.81 26,208 No 4 M Indirect By LCK Investment LLC
Common Stock Disposition 2019-11-15 25,000 $42.81 1,208 No 4 S Indirect By LCK Investment LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Indirect By LCK Investment LLC
No 4 S Indirect By LCK Investment LLC
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-15 25,000 $0.00 25,000 $10.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
288,670 2022-06-05 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 18,596 Indirect By Stack Schroon Mohawk FLP
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.200 to $43.025, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4.
  3. Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.245 to $43.020, inclusive.
  5. The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.